PALMIERI, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 17.548
AS - Asia 10.401
SA - Sud America 6.422
EU - Europa 4.674
AF - Africa 398
Continente sconosciuto - Info sul continente non disponibili 41
OC - Oceania 39
Totale 39.523
Nazione #
US - Stati Uniti d'America 17.128
BR - Brasile 5.727
SG - Singapore 4.957
CN - Cina 2.284
UA - Ucraina 1.329
HK - Hong Kong 960
VN - Vietnam 829
DE - Germania 618
FR - Francia 593
IT - Italia 576
SE - Svezia 423
FI - Finlandia 308
GB - Regno Unito 213
AR - Argentina 204
TR - Turchia 182
CA - Canada 161
MX - Messico 151
IN - India 148
BD - Bangladesh 143
IQ - Iraq 134
EC - Ecuador 131
RU - Federazione Russa 125
ZA - Sudafrica 108
VE - Venezuela 94
MA - Marocco 93
JP - Giappone 82
CO - Colombia 80
UZ - Uzbekistan 79
PL - Polonia 73
PK - Pakistan 69
KR - Corea 68
AT - Austria 66
NL - Olanda 61
PY - Paraguay 50
ES - Italia 49
CL - Cile 48
JO - Giordania 48
KE - Kenya 48
TN - Tunisia 45
ID - Indonesia 44
AZ - Azerbaigian 42
BE - Belgio 39
AE - Emirati Arabi Uniti 37
AU - Australia 36
UY - Uruguay 35
NP - Nepal 31
PE - Perù 29
RO - Romania 28
EU - Europa 27
KZ - Kazakistan 27
AL - Albania 26
LT - Lituania 25
OM - Oman 25
DZ - Algeria 24
CZ - Repubblica Ceca 23
JM - Giamaica 22
LB - Libano 22
BO - Bolivia 20
EG - Egitto 20
SA - Arabia Saudita 20
KG - Kirghizistan 19
HN - Honduras 18
IL - Israele 18
DO - Repubblica Dominicana 17
IR - Iran 16
PH - Filippine 16
RS - Serbia 16
BH - Bahrain 15
SN - Senegal 15
CH - Svizzera 13
PA - Panama 13
SY - Repubblica araba siriana 12
CI - Costa d'Avorio 11
GE - Georgia 11
PS - Palestinian Territory 11
BY - Bielorussia 10
CR - Costa Rica 10
IE - Irlanda 10
AM - Armenia 9
BG - Bulgaria 9
NI - Nicaragua 8
XK - ???statistics.table.value.countryCode.XK??? 8
ET - Etiopia 7
MN - Mongolia 7
MY - Malesia 7
TT - Trinidad e Tobago 7
A2 - ???statistics.table.value.countryCode.A2??? 6
GT - Guatemala 6
KW - Kuwait 6
NG - Nigeria 6
AO - Angola 5
BN - Brunei Darussalam 5
GR - Grecia 5
LK - Sri Lanka 5
MD - Moldavia 5
BA - Bosnia-Erzegovina 4
DK - Danimarca 4
HU - Ungheria 4
PT - Portogallo 4
GA - Gabon 3
Totale 39.468
Città #
Dallas 6.120
Singapore 2.719
Chandler 2.350
San Jose 1.449
Hong Kong 948
Ashburn 795
Princeton 768
Jacksonville 661
Beijing 428
São Paulo 390
Lauterbourg 373
Ho Chi Minh City 304
Wilmington 288
Dearborn 276
Nanjing 262
Shanghai 251
Hanoi 195
Santa Clara 179
Belo Horizonte 172
New York 165
Rio de Janeiro 158
Los Angeles 155
Ann Arbor 150
Helsinki 141
Boardman 125
Brasília 113
Nanchang 112
Sassari 109
Orem 88
Porto Alegre 82
Curitiba 81
Campinas 80
Frankfurt am Main 80
Tokyo 79
Columbus 74
The Dalles 74
Tianjin 72
Council Bluffs 70
Seoul 67
Tashkent 67
Nuremberg 65
Shenyang 61
Warsaw 61
San Francisco 60
Changsha 55
Norwalk 55
Guarulhos 54
Johannesburg 54
Hebei 53
Baghdad 52
Jiaxing 51
Toronto 49
Da Nang 48
Amman 47
Goiânia 47
Montreal 44
Osasco 44
Chennai 42
Munich 42
Nairobi 42
Mexico City 41
Ribeirão Preto 41
Salvador 41
Santo André 40
Brooklyn 39
Brussels 39
Dhaka 39
Guayaquil 39
Istanbul 39
Fortaleza 38
Buffalo 37
Chicago 36
Manaus 36
Mountain View 36
Falls Church 35
Haiphong 35
Quito 35
Stockholm 35
Vienna 35
Woodbridge 35
Betim 34
Amsterdam 33
Atlanta 33
Baku 33
Caxias do Sul 33
Joinville 33
Sorocaba 33
São Bernardo do Campo 33
Ankara 32
Cagliari 32
London 32
Milan 32
Recife 32
Campo Grande 31
Kunming 31
Denver 29
Juiz de Fora 29
Pelotas 29
Poplar 29
Falkenstein 28
Totale 23.478
Nome #
Clinical, Histopathological, Dermoscopic Features, and BRAF, NRAS, and Cell Cycle Genes’ Mutation Status in Cutaneous Melanoma 1.167
A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis 345
KRAS mutations in Non-Small Cell Lung Cancer: translational aspects, current therapies and challenges for future research 307
Allelic Gains And Losses At 10q25-Q26 In Malignancies Of The Uterine Corpus: Demonstration Of Two Distinctive Genetic Alterations 281
EGFR mutation detection in Whole Slide Images of non-small cell lung cancers using a two-stage deep transfer learning approach 263
Aspetti epidemiologici dei tumori maligni dell’ovaio nel Nord Sardegna nel periodo 1992-2001 250
Analysis of fanconi anemia genes in colorectal cancer 205
A Founder Mutation In Sardinian Breast Cancer Families Detected By Identity-By-Descent Method 196
Analysis of the mapk-erk gene pathway in primary and metastatic melanoma cell lines 193
A role of BRCA1 and BRCA2 germline mutations in breast cancer susceptibility within Sardinian population 192
KIT and PDGFRa mutational patterns in Sardinian patients with gastrointestinal stromal tumors 187
Analysis of candidate genes through a proteomics-based approach in primary cell lines from malignant melanomas and their metastases 187
Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas 186
Breast cancer incidence and mortality in North Sardinia in the period 1992 - 2010 178
Dermoscopy and confocal microscopy for metachronous multiple melanomas: morphological, clinical, and molecular correlations 178
A novel candidate gene in human endometrial cancer at chromosome 10q26 177
Jagged 1 is a major Notch ligand along cholangiocarcinoma development in mice and humans 177
Deciduoid mesothelioma of the thorax: A comprehensive review of the scientific literature 174
Epidemiology of thyroid cancer in an area of epidemic thyroid goiter 173
CASC2a gene is down-regulated in endometrial cancer 165
A Diagnostic of Acquired Hemophilia Following PD1/PDL1 Inhibitors in Advanced Melanoma: The Experience of Two Patients and a Literature Review 164
Are Molecular Alterations Linked to Genetic Instability Worth to Be Included as Biomarkers for Directing or Excluding Melanoma Patients to Immunotherapy? 164
Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study 164
Breast Nodular Fasciitis: A Comprehensive Review 163
EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1,440 Sardinian patients with lung adenocarcinoma. 158
Long non-coding RNA CASC2 in human cancer 158
Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis 158
Phenotype characterization of human melanoma cells resistant to dabrafenib 155
Comparison of BRAF Mutation Screening Strategies in a Large Real-Life Series of Advanced Melanoma Patients 154
Disease progression and overall survival in sardinian patients with colorectal cancer according to the kras mutational status 150
Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach 149
Breast cancer incidence and mortality in North Sardinia in the period 1992–2010 146
Genetic alterations in main candidate genes during melanoma progression 143
Female Adnexal Tumors of Probable Wolffian Origin (FATWO): A Case Series with Next-Generation Sequencing Mutation Analysis 141
Dietary compounds and cutaneous malignant melanoma: recent advances from a biological perspective 140
Fanconi genes may contribute to melanoma pathogenesis 140
Colorectal cancer epidemiology in an area with a spontaneous screening program 139
Presence of Jaagsiekte sheep retrovirus in tissue sections from human bronchioloalveolar carcinoma depends on patients' geographical origin 138
Genetic Instability Markers in Cancer 137
Epidemiology and genetic susceptibility of malignant melanoma in North Sardinia, Italy 137
Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study 136
Fanconi genes are altered in subsets of patients with sporadic colorectal carcinoma 135
Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma 134
Global prognostic impact of driver genetic alterations in patients with lung adenocarcinoma: a real-life study 134
Mutation analysis of mucosal and cutaneous melanomas during progression 133
Repurposing anticancer drugs for the treatment of idiopathic pulmonary fibrosis and antifibrotic drugs for the treatment of cancer: state of the art 133
Cytogenetic assessment of the involvement of a new locus at 9p21 in malignant melanoma 132
BRAF mutations and dysregulation of the MAP kinase pathway associated to sinonasal mucosal melanomas 132
Adjuvant therapy of cutaneous melanoma 132
Microsatellite analysis at 10q25-q26 in Sardinian patients with sporadic endometrial carcinoma - Identification of specific patterns of genetic alteration 131
Adjuvant treatment of malignant melanoma: where are we? 131
Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy 130
Head and neck cancer epidemiology in North Sardinia, Italy. 129
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: A survey of young oncologists 129
Molecular classification of patients with malignant melanoma for new therapeutic strategies 128
Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI) 127
KRAS mutational concordance between primary and metastatic colorectal adenocarcinoma 126
Detection of occult melanoma cells in paraffin-embedded histologically negative sentinel lymph nodes using a reverse transcriptase polymerase chain reaction assay 126
Antitumoral effect of vanadium compounds in malignant melanoma cell lines 125
Molecular epidemiology of the main druggable genetic alterations in non-small cell lung cancer 123
Uterine perivascular epithelioid cell neoplasms (PEComas): Report of two cases and literature review 123
X-inactivation patch size in human female tissue confounds the assessment of tumor clonality 122
Epidemiology of malignant pleural mesothelioma in the province of Sassari (Sardinia, Italy). A population-based report 122
Antiproliferative and pro-apoptotic activity of eugenol-related biphenyls on malignant melanoma cells 122
Epidemiological aspects of ovarian malignancies in North Sardinia in the period 1992-2001 121
Microsatellite analysis at 10q25-q26 in Sardinian patients with sporadic endometrial carcinoma 121
2,2’-dihydroxy-3,3’-dimethoxy-5,5’-dimethyl-6,6’-dibromo-1,1’-biphenyl: preparation, resolution, structure and biological activity 121
BRCA1 and BRCA2 mutation analysis in breast cancer families from Sardinia 119
Microsatellite and fish analysis in endometrial cancer: Assessment of specific patterns of genetic and cytogenetic alterations with their clinical correlations 119
Protein expression changes induced in a malignant melanoma cell line by the curcumin analogue compound D6 119
Human gene mutations gene symbol: BRCA2 small insertion in breast cancer 119
Primary dermal melanoma in a patient with a history of multiple malignancies: a case report with molecular characterization 118
Antiproliferative activity of vanadium compounds: Effects on the major malignant melanoma molecular pathways 118
Immunohistochemistry and biomolecular investigation for the evidence of JSRV-like retrovirus in human bronchiolo-alveolar carcinomas 118
Actin-binding protein (ABP-280) filamin gene maps telomeric to the color vision locus (R/GCP) and centromeric to G6PD in Xq28. 117
The effect of COVID-19 emergency in the management of melanoma in Italy 117
An evaluation of talazoparib plus enzalutamide for the treatment of metastatic castration-resistant prostate cancer 117
Mutational analysis of candidate genes in families with malignant melanoma (MM): assessment of the role of the CDKN2A gene in MM predispositions 115
Squamous cell carcinoma arising in mature cystic teratoma of the ovary: report of two cases with molecular analysis 115
Germline mutations in candidate genes among patients with cutaneous melanoma from Sardinia 114
A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation 114
A Role ofBRCA1andBRCA2germline mutations in breast cancer susceptibility within Sardinian population 114
Screening for founder mutations in BRCA1/2 tumor susceptibility genes among breast cancer families from North Sardinia 114
Pancreatic cancer burden in North Sardinia, Italy 114
Indagini immunoistochimiche e biomolecolari per l’evidenziazione di retrovirus jsrv-correlati, in carcinomi bronchiolo-alveolari dell’uomo 114
1.5-Mb YAC contig in Xq28 formatted with sequence-tagged sites and including a region unstable in the clones 113
BRAF and PIK3CA genes are somatically mutated in hepatocellular carcinoma among patients from South Italy 112
3-year treatment with recombinant interferon- as adjuvant therapy of cutaneous malignant melanoma. 111
Identification of different patterns of genetic alteration (a new minimal LOH region at chromosome 10q25-26 and genomic instability) in Sardinian patients with sporadic endometrial cancer and correlation with clinicopathological parameters 111
Assessment of the role of Fanconi Anemia (FA) genes in colorectal cancer: A new pathogenetic pathway? 110
Origin and distribution of the BRCA2-8765delAG mutation in breast cancer 110
Assessment of genetic instability in melanocytic skin lesions through microsatellite analysis of benign naevi, dysplastic naevi, and primary melanomas and their metastases 109
Synchronous interdigitating dendritic cell sarcoma and B-cell small lymphocytic lymphoma in a lymph node 109
Assessment of microsatellite instability in benign nevi, dysplastic nevi, and primary melanomas along with their metastases 109
Low Levels of Genetic Heterogeneity in Matched Lymph Node Metastases from Patients with Melanoma 109
Primary melanoma of the lung: A systematic review 109
An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival 109
Enhanced anti-tumor activity of a newcurcumin-related compound against melanoma and neuroblastoma cells 108
X-inactivation patch size in human female tissue confounds the assessment of tumor clonality 108
Role of BRCA2 mutation status on overall survival among breast cancer patients from Sardinia 108
Totale 15.377
Categoria #
all - tutte 176.209
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 176.209


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202179 0 0 0 0 0 0 0 0 0 0 0 79
2021/20221.591 150 8 7 28 21 35 81 129 144 130 171 687
2022/20234.418 431 204 76 818 370 874 2 493 803 36 187 124
2023/20241.088 260 119 29 36 125 81 26 109 3 19 93 188
2024/202511.568 93 83 657 213 405 510 489 2.503 4.350 1.556 427 282
2025/202616.652 465 5.038 2.153 2.074 1.574 931 2.281 473 690 605 289 79
Totale 40.020